| scholarly article | Q13442814 |
| P50 | author | Simon R. Taylor | Q42590171 |
| John H Kempen | Q63819726 | ||
| P2093 | author name string | Janet T Holbrook | |
| Elizabeth A Sugar | |||
| Igor Kozak | |||
| William R Freeman | |||
| Douglas A Jabs | |||
| Michael M Altaweel | |||
| Susan L Lightman | |||
| Glen J Jaffe | |||
| P2860 | cites work | Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop | Q24727581 |
| Longitudinal data analysis for discrete and continuous outcomes | Q29547235 | ||
| Serous macular detachment as a predictor of resolution of macular edema with intravitreal triamcinolone injection | Q30859977 | ||
| Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia | Q33304930 | ||
| Smoking as a risk factor for cystoid macular edema complicating intermediate uveitis | Q33322621 | ||
| Correlation between morphologic features on spectral-domain optical coherence tomography and angiographic leakage patterns in macular edema | Q33538990 | ||
| Relationship between optical coherence tomography retinal parameters and visual acuity in diabetic macular edema | Q33609377 | ||
| Cigarette smoking as a risk factor for uveitis | Q33695558 | ||
| Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. | Q33920749 | ||
| The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics | Q34286402 | ||
| Degree, duration, and causes of visual loss in uveitis. | Q35592376 | ||
| Uveitis: a potentially blinding disease. | Q35838711 | ||
| Correlation of retinal sensitivity measured with fundus-related microperimetry to visual acuity and retinal thickness in eyes with diabetic macular edema | Q36195635 | ||
| Causes and frequency of blindness in patients with intraocular inflammatory disease | Q37319691 | ||
| Understanding uveitis: the impact of research on visual outcomes | Q37909585 | ||
| The natural history of uveitis | Q38002324 | ||
| Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results | Q38387242 | ||
| Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography | Q44879359 | ||
| Quantitative analysis of central visual field defects in macular edema using three-dimensional computer-automated threshold Amsler grid testing | Q45291334 | ||
| Uveitic macular oedema: correlation between optical coherence tomography patterns with visual acuity and fluorescein angiography. | Q46520542 | ||
| Tomographic assessment of therapeutic response to uveitic macular oedema | Q46903671 | ||
| Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis. | Q54037377 | ||
| Diabetic Macular Edema: Correlation between Microperimetry and Optical Coherence Tomography Findings | Q63348863 | ||
| Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group | Q69874090 | ||
| New visual acuity charts for clinical research | Q70389078 | ||
| Standardized illumination for visual acuity testing in clinical research | Q70389079 | ||
| Reading performance of patients with uveitis-associated cystoid macular edema | Q79164924 | ||
| Risk factors for cystoid macular oedema in patients with uveitis | Q79196584 | ||
| Impact of macular edema on visual acuity in uveitis | Q80023608 | ||
| Course of macular edema in uveitis under medical treatment | Q80454666 | ||
| Central visual field impairment during and following cystoid macular oedema | Q80527058 | ||
| Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study | Q83321961 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 171-181 | |
| P577 | publication date | 2012-04-24 | |
| P1433 | published in | Ocular Immunology and Inflammation | Q15760486 |
| P1476 | title | The impact of macular edema on visual function in intermediate, posterior, and panuveitis | |
| P478 | volume | 20 |
| Q48288484 | Adalimumab in refractory cystoid macular edema associated with birdshot chorioretinopathy |
| Q91787718 | Association between Macular Thickness Profiles and Visual Function in Healthy Eyes: The Singapore Epidemiology of Eye Diseases (SEED) Study |
| Q37412317 | Birdshot uveitis: current and emerging treatment options |
| Q38074447 | Clinical characteristics of intermediate uveitis in Chinese patients |
| Q35964507 | Clinical characteristics of intermediate uveitis in adult Turkish patients |
| Q91804757 | Defining outcome measures in juvenile idiopathic arthritis associated uveitis by a systematic review analysis: do we need a consensus? |
| Q38552030 | Development of a dexamethasone intravitreal implant for the treatment of noninfectious posterior segment uveitis |
| Q38977592 | Efficacy of Anti-IL6-Receptor Tocilizumab in Refractory Cystoid Macular Edema of Birdshot Retinochoroidopathy Report of Two Cases and Literature Review. |
| Q37135393 | Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema |
| Q26796779 | Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis |
| Q35065882 | Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema |
| Q40825859 | Influence of baseline demographic and clinical characteristics in the visual outcome of intermediate uveitis: a survival analysis |
| Q34325614 | Longitudinal comparison of visual acuity as measured by the ETDRS chart and by the potential acuity meter in eyes with macular edema, and its relationship with retinal thickness and sensitivity |
| Q90397147 | Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges |
| Q37245815 | Morphological assessment of the retina in uveitis |
| Q36218114 | Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results |
| Q37038644 | Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial |
| Q28068067 | The effectiveness of pharmacological agents for the treatment of uveitic macular oedema (UMO): a systematic review protocol |
| Q45903627 | Tocilizumab treatment for refractory uveitis-related cystoid macular edema. |
Search more.